The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
Open Access
- 1 March 2000
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 95 (5) , 1680-1686
- https://doi.org/10.1182/blood.v95.5.1680.005k33_1680_1686
Abstract
The influence of the endothelial protein C receptor (EPCR) on the host response to Escherichia coli was studied. Animals were treated with 4 separate protocols for survival studies and analysis of physiologic and biochemical parameters: (1) monoclonal antibody (mAb) that blocks protein C/activated protein C binding to EPCR plus sublethal numbers of E coli (SLEC) (n = 4); (2) mAb to EPCR that does not block binding plus SLEC (n = 3); (3) SLEC alone (n = 4); and (4) blocking mAB alone (n = 1). Those animals receiving blocking mAb to EPCR plus sublethal E coli died 7 to 54 hours after challenge, whereas all animals treated with the other protocols were permanent survivors. Histopathologic studies of tissues from animals receiving blocking mAb plus SLEC removed at postmortem were compared with those animals receiving SLEC alone killed at T+24 hours. The animals receiving the blocking mAb exhibited consumption of fibrinogen, microvascular thrombosis with hemorrhage of both the adrenal and renal cortex, and an intense influx of neutrophils into the adrenal, renal, and hepatic microvasculature, whereas the tissues from animals receiving only sublethal E coli exhibited none of these abnormal histopathologic changes. Compared with the control animals, the animals receiving the blocking mAb exhibited significantly elevated serum glutamic pyruvic transaminase, anion gap, thrombin-antithrombin complex, IL-6, IL-8, and soluble thrombomodulin. The levels of circulating activated protein C varied too widely to allow a clear determination of whether the extent of protein C activation was altered in vivo by blocking protein C binding to EPCR. We conclude that protein C/activated protein C binding to EPCR contributes to the negative regulation of the coagulopathic and inflammatory response to E coli and that EPCR provides an additional critical step in the host defense against E coli.Keywords
This publication has 47 references indexed in Scilit:
- Impaired Anticoagulant Response to Infusion of Thrombin in Atherosclerotic Monkeys Associated With Acquired Defects in the Protein C SystemArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Identification of functional endothelial protein C receptor in human plasma.Journal of Clinical Investigation, 1997
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- The Endothelial Cell Protein C ReceptorJournal of Biological Chemistry, 1996
- The Endothelial Cell Protein C ReceptorJournal of Biological Chemistry, 1996
- Summary of Staging Mechanism and Intervention Studies in the Baboon Model of E. coli SepsisPublished by Wolters Kluwer Health ,1990
- Purpura Fulminans in Meningococcemia: Association with Acquired Deficiencies of Proteins C and SNew England Journal of Medicine, 1987
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987
- Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.Journal of Clinical Investigation, 1987
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986